Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Perilipin-1 in hemodialyzed patients: association with history of coronary heart disease and lipid profile.

Eleftheriadis T, Antoniadi G, Liakopoulos V, Pissas G, Arampatzis S, Sparopoulou T, Galaktidou G, Stefanidis I.

Ther Apher Dial. 2012 Aug;16(4):355-60. doi: 10.1111/j.1744-9987.2012.01080.x. Epub 2012 Jun 7.

PMID:
22817124
2.

Arginase type I as a marker of coronary heart disease in hemodialysis patients.

Eleftheriadis T, Liakopoulos V, Antoniadi G, Stefanidis I, Galaktidou G.

Int Urol Nephrol. 2011 Dec;43(4):1187-94. doi: 10.1007/s11255-010-9842-4. Epub 2010 Sep 15.

PMID:
20842428
3.

Do insulin resistance conditions further impair the lipid and inflammatory profile in end-stage renal disease patients on hemodialysis?

Cacciagiú L, González AI, Elbert A, De'Marziani G, Machida T, Murakami M, López GI, Wikinski R, Nakajima K, Schreier L.

Metab Syndr Relat Disord. 2014 May;12(4):220-6. doi: 10.1089/met.2013.0124. Epub 2014 Mar 6.

PMID:
24601848
4.

Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.

Siamopoulos KC, Elisaf MS, Bairaktari HT, Pappas MB, Sferopoulos GD, Nikolakakis NG.

Perit Dial Int. 1995 Oct-Dec;15(8):342-7.

PMID:
8785232
5.

Effect of intradialytic parenteral nutrition in patients with malnutrition-inflammation complex syndrome on body weight, inflammation, serum lipids and adipocytokines: results from a pilot study.

Joannidis M, Rauchenzauner M, Leiner B, Rosenkranz A, Ebenbichler CF, Laimer M, Tatarczyk T, Meusburger E, Mayer G.

Eur J Clin Nutr. 2008 Jun;62(6):789-95. Epub 2007 May 16.

PMID:
17522619
6.

An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.

Stompór T, Pasowicz M, Sulłowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E.

Am J Kidney Dis. 2003 Jan;41(1):203-11.

PMID:
12500238
7.

Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities.

Khalatbari Soltani S, Jamaluddin R, Tabibi H, Mohd Yusof BN, Atabak S, Loh SP, Rahmani L.

Hemodial Int. 2013 Apr;17(2):275-81. doi: 10.1111/j.1542-4758.2012.00754.x. Epub 2012 Sep 24.

PMID:
22998533
8.

Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.

Szklarek-Kubicka M, Fijałkowska-Morawska J, Zaremba-Drobnik D, Uciński A, Czekalski S, Nowicki M.

J Ren Nutr. 2009 Nov;19(6):487-93. doi: 10.1053/j.jrn.2009.05.007. Epub 2009 Jul 17.

PMID:
19616450
9.

Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.

Perunicic-Pekovic G, Pljesa S, Rasic-Milutinovic Z, Stankovic S, Ilic M, Maletic R.

Can J Physiol Pharmacol. 2008 Apr;86(4):205-9. doi: 10.1139/Y08-018.

PMID:
18418430
10.

The serum lipids levels may be underestimated in patients on hemodialysis.

Ueno T, Doi S, Nakashima A, Yokoyama Y, Doi T, Kawai T, Kusano Y, Ueda C, Masaki T.

Intern Med. 2015;54(8):887-94. doi: 10.2169/internalmedicine.54.2997. Epub 2015 Apr 15.

11.

Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?

Jakić M, Lovcić V, Klarić D, Mihaljević D, Zibar L, Jakić M, Marić I.

Coll Antropol. 2010 Mar;34 Suppl 1:181-8.

PMID:
20402316
12.

Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.

Daud ZA, Tubie B, Adams J, Quainton T, Osia R, Tubie S, Kaur D, Khosla P, Sheyman M.

Vasc Health Risk Manag. 2012;8:187-95. doi: 10.2147/VHRM.S28739. Epub 2012 Mar 20.

13.

An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients.

Erten Y, Tulmac M, Derici U, Pasaoglu H, Altok Reis K, Bali M, Arinsoy T, Cengel A, Sindel S.

Ren Fail. 2005;27(5):581-9.

PMID:
16152997
14.

Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.

González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.

Metabolism. 2003 Jan;52(1):116-21.

PMID:
12524671
15.

Association between circulating leptin and soluble receptors for tumor necrosis factor-alpha in hemodialysis patients.

Kato A, Odamaki M, Maruyama Y, Hishida A.

Clin Nephrol. 2001 Nov;56(5):370-7.

PMID:
11758007
16.

Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.

Tomura S, Nakamura Y, Doi M, Ando R, Ida T, Chida Y, Ootsuka S, Shinoda T, Yanagi H, Tsuchiya S, Marumo F.

Am J Kidney Dis. 1996 Jun;27(6):848-54.

PMID:
8651250
17.

Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants.

Caliskan Y, Yelken B, Gorgulu N, Ozkok A, Yazici H, Telci A, Turkmen A, Yildiz A, Sever MS.

J Ren Nutr. 2012 Mar;22(2):258-67. doi: 10.1053/j.jrn.2011.07.005. Epub 2011 Nov 3.

PMID:
22056149
18.

Malnutrition, inflammation, and lipids in a cohort of dialysis patients.

Bowden RG, Wilson RL.

Postgrad Med. 2010 May;122(3):196-202. doi: 10.3810/pgm.2010.05.2158.

PMID:
20463430
19.

Plasma indoleamine 2,3-dioxygenase concentration is increased in hemodialysis patients and may contribute to the pathogenesis of coronary heart disease.

Eleftheriadis T, Antoniadi G, Liakopoulos V, Stefanidis I, Galaktidou G.

Ren Fail. 2012;34(1):68-72. doi: 10.3109/0886022X.2011.623562. Epub 2011 Oct 21.

PMID:
22017594
20.

A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.

Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.

Chin Med J (Engl). 2004 Feb;117(2):163-7.

PMID:
14975195

Supplemental Content

Support Center